Article
KRAS-specific Amino Acid Substitutions are Associated With Different Responses to Chemotherapy in Advanced Non-small-cell Lung Cancer.
Clinical lung cancer - 1 Nov 2018
Renaud Stéphane, Guerrera Francesco, Seitlinger Joseph, Reeb Jérémie, Voegeli Anne-Claire, Legrain Michèle, Mennecier Bertrand, Santelmo Nicola, Falcoz Pierre-Emmanuel, Quoix Elisabeth, Chenard Marie-Pierre, Weingertner Noëlle, Beau-Faller Michèle, Massard Gilbert
Abstract excerpt
BACKGROUND: Emerging data highlight different clinical behaviors according to KRAS amino acid substitutions (AASs) in patients with non-small-cell lung cancer (NSCLC). We aimed to evaluate whether different KRAS AASs were associated with different responses to chemotherapy. PATIENTS AND METHODS: We retrospectively reviewed data from 1190 patients with KRAS mutations who underwent first-line platinum-based...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
